← Evidence map

ArticleExperimental and therapeutic medicine2019

Ginsenoside Rg3 promotes the antitumor activity of gefitinib in lung cancer cell lines.

Yuemei Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30651886